DHX8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.163400E-01
Normal-vs-Stage2
8.170000E-01
Normal-vs-Stage3
8.092800E-01
Normal-vs-Stage4
4.689400E-01
Stage1-vs-Stage2
8.847800E-01
Stage1-vs-Stage3
8.646600E-01
Stage1-vs-Stage4
1.816150E-01
Stage2-vs-Stage3
8.828400E-01
Stage2-vs-Stage4
2.394400E-01
Stage3-vs-Stage4
4.875600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.890200E-01
Normal-vs-AfricanAmerican
6.978000E-01
Normal-vs-Asian
3.727200E-01
Caucasian-vs-AfricanAmerican
3.184600E-01
Caucasian-vs-Asian
4.250800E-01
AfricanAmerican-vs-Asian
1.292630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.138200E-01
Normal-vs-Female
8.125000E-01
Male-vs-Female
9.529000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.438600E-01
Normal-vs-Age(41-60Yrs)
7.649000E-01
Normal-vs-Age(61-80Yrs)
5.499000E-01
Normal-vs-Age(81-100Yrs)
8.667400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.876200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.334600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.267200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.876000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.025400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.099800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.351400E-01
Normal-vs-Daily Drinker
5.732000E-01
Normal-vs-Weekly Drinker
2.884800E-01
Normal-vs-Occasional Drinker
6.519800E-01
Normal-vs-Social Drinker
8.375400E-01
Non Drinker-vs-Daily Drinker
8.364800E-01
Non Drinker-vs-Weekly Drinker
6.760600E-01
Non Drinker-vs-Occasional Drinker
3.636300E-02
Non Drinker-vs-Social Drinker
1.230830E-01
Daily Drinker-vs-Weekly Drinker
5.347800E-01
Daily Drinker-vs-Occasional Drinker
6.348300E-02
Daily Drinker-vs-Social Drinker
1.710850E-01
Weekly Drinker-vs-Occasional Drinker
3.277900E-02
Weekly Drinker-vs-Social Drinker
5.788100E-02
Occasional Drinker-vs-Social Drinker
5.693600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.313900E-02
Normal-vs-Grade 2
1.151910E-02
Normal-vs-Grade 3
9.384800E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.410400E-02
Grade 1-vs-Grade 3
1.868200E-02
Grade 1-vs-Grade 4
8.313900E-02
Grade 2-vs-Grade 3
2.459000E-01
Grade 2-vs-Grade 4
1.151910E-02
Grade 3-vs-Grade 4
9.384800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.457600E-01
Normal-vs-NonDiabetic
8.324400E-01
Diabetic-vs-NonDiabetic
1.033420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.646600E-01
Normal-vs-NoPancreatitis
7.324800E-01
Pancreatitis-vs-NoPancreatitis
4.571000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.500200E-01
Normal-vs-N1
8.126000E-01
N0-vs-N1
8.362400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.100400E-01
Normal-vs-TP53-NonMutant
6.586000E-01
TP53-Mutant-vs-TP53-NonMutant
7.083000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
